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Peroxiredoxin 6 (Prdx6) is a pleiotropic oxidative stress-response protein that defends cells against reactive oxygen species
(ROS)-induced damage. Curcumin, a naturally occurring agent, has diversiﬁed beneﬁcial roles including cytoprotection. Using
humanlensepithelialcells(hLECs)andPrdx6-deﬁcientcells,weshowtheevidencethatcurcuminprotects cellsbyupregulating
Prdx6 transcription via invoking speciﬁcity protein 1 (Sp1) activity against proapoptotic stimuli. Curcumin enhanced Sp1 and
Prdx6 mRNA and protein expression in a concentration-dependent manner, as evidenced by western and real-time PCR
analyses, and thereby negatively regulated ROS-mediated apoptosis by blunting ROS expression and lipid peroxidation.
Bioinformatic analysis and DNA–protein binding assays disclosed three active Sp1 sites ( 19/27,  61/69 and  82/89) in Prdx6
promoter. Co-transfection experiments with Sp1 and Prdx6 promoter–chloramphenicol acetyltransferase (CAT) constructs
showedthatCATactivitywasdramaticallyincreasedinLECsorSp1-deﬁcient cells(SL2).CurcumintreatmentofLECsenhanced
Sp1 binding to its sites, consistent with curcumin-dependent stimulation of Prdx6 promoter with Sp1 sites and cytoprotection.
Notably, disruption of Sp1 sites by point mutagenesis abolished curcumin transactivation of Prdx6. Also, curcumin failed to
activate Prdx6 expression in the presence of Sp1 inhibitors, demonstrating that curcumin-mediated increased expression of
Prdx6 was dependent on Sp1 activity. Collectively, the study may provide a foundation for developing transcription-based
inductive therapy to reinforce endogenous antioxidant defense by using dietary supplements.
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Many biologically relevant elements in the cellular and
external environments, such as growth factors, chemicals
and ultraviolet B (UVB) radiation, have been shown to initiate
reactive oxygen species (ROS)-evoked deleterious signaling
in cells by disruption of the antioxidant system and conse-
quently of cellular homeostasis.
1–5 Moreover, elevated levels
of ROS have been reported in aging cells, in cells and tissues
developing pathophysiology, and in tissue ﬂuids, including the
aqueous humor of cataract patients, potentially causing cell
death or opaciﬁcation of lens in vitro. Augmentation of the
antioxidant defenses in the ocular lens has been shown to
prevent or delay cataractogenesis.
2,6 Recent studies have
demonstrated that a major event in the progression of age-
associated disorders is the decline in expression and activity
of natural antioxidant such as peroxiredoxin 6 (Prdx6).
2,4,6,7
However, how transcriptional machinery controls Prdx6
expression and how Prdx6 transcription could be modulated
under normal physiological condition is obscure. Moreover,
one of the key systems involved in maintenance of the
intracellular redox state is the antioxidant defense system,
which includes catalase, SODs, Gpx1, Trx and Prdxs. The
Prdxs family of proteins comprises six members, Prdx1–6,
each of which contains either one cysteine (1-Cys) or two
(2-Cys). Redox-active Cys residues play a role in controlling
intracellular ROS expression. Prdxs are important in main-
taining many cellular functions, including redox control of
transcription factors.
6,8 Importantly, Prdx6 (a 1-Cys Prdx),
unlike classical glutathione peroxidase or other Prdxs,has the
ability to reduce phospholipid hydroperoxides by such means
as peroxidation of membrane phospholipids during oxidative
stress, thereby controlling phospholipid turnover.
2,4,9 Research
using targeted inactivation of Prdx6 gene in under- and over-
expression experiments and animal studies has shown that
Prdx6 with GSH peroxidase and acidic Ca
2þ-independent
phospholipase A2 activities is essential for cell survival.
6,7
In cells subjected to oxidative stress, Prdx6 expression is
vitally important for survival.
2–4
However, the potential for intracellular delivery of mature
protein or DNA for therapeutic purposes has been limited
owing to the impermeable nature of selective plasma mem-
brane. Current therapies for age-related degenerative dis-
eases have been jeopardized owing to several setbacks in
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www.nature.com/cddisDNA and/or protein delivery. Curcumin is a pharmacologically
safe agent
10,11 with many activities including a powerful
antioxidant function and anti-inﬂammatory properties.
12,13
This agent has been found to induce expression of the
antioxidant enzymes in various cell types.
14–16 Curcumin
mediates its effects by modulating several important mole-
cular targets, including transcription factors NF-kB, Ap1 and
speciﬁcity protein 1 (Sp1).
15,17–19 Recently, curcumin has
been shown to suppress NF-kB activation
10,14 and activate
the transcription factor Sp1. Sp1 is a stress-inducible,
antideath transcriptional factor with a wide spectrum of
beneﬁcial activity, which it exerts by binding to a GC-rich
element (or GC-box) in the promoter of target genes.
20
Importantly, Sp1 functionally cooperates with a large number
of sequence-speciﬁc transcription factors such as NF-kB,
Oct 1 and GATA-1.
21 However, most studies related to
identiﬁcation of responsive elements in the 50 region of
human, mouse and rat Prdx6 gene promoter have described
several redox-active transcription factors such as Sp1, Ap1,
NRF2, NF-kB, HSF1 and LEDGF,
3,6 suggesting that Prdx6
geneissubjectedtocomplextranscriptionalregulation.These
elements account for the transcriptional responses to oxidant
and non-oxidant stimuli.
In this study, we demonstrate that curcumin signiﬁcantly
induced Sp1 mRNA and protein that physically and function-
ally bound to all three Sp1-responsive elements (GC-box) in
50-proximal region of Prdx6 gene promoter in vitro and in vivo,
and that curcumin enhanced Prdx6 transactivation. In addi-
tion, we showed that curcumin-mediated Sp1-enhanced
activity was directly related to increased transcription of Prdx6
gene and thereby abundance of its mRNA and protein – a
process that is involved in curcumin-mediated negative regula-
tion of oxidative stress-induced death signaling in hLECs.
Results
Curcumin protected hLECs from UVB-, H2O2-o r
paraquat-induced cell injury. To determine an effective
non-cytotoxic concentration(s), hLECs were treated with
various concentrations (0–10mM) of curcumin, and cell
growth was assessed at different time points. After pro-
longed treatment (24, 48 or 72h), hLECs treated with 5mM
had shown better growth, while cells treated with 10mM
showed growth inhibition (data not shown). Thus, 5mM con-
centration of curcumin was chosen as the optimum effective
dose and has been used throughout the study until and
unless stated. In addition, to show the evidence of curcumin-
mediated survival signaling, we utilized different sources to
induced oxidative stress, UVB, H2O2 and paraquat.
2,22
To examine whether curcumin blunted the apoptosis
induced by UVB, we exposed curcumin-pretreated hLECs to
variable doses of UVB radiation. Figures 1A and B illustrate
time-dependent enhanced viability of hLECs (Figure 1A, dark
gray bars versus black bars) and reduced expression of ROS
(Figure 1B, dark gray bars versus black bars) with variable
levels of UVB exposure (50, 100 or 200J/m
2) after 5mM
treatment with curcumin for 24, 48 or 72h. Data revealed that
curcumin, indeed, protected hLECs from UVB-induced stress
as evidenced by photomicrographed (Figures 1Ca and b).
We alsoconducted apoptoticcell assay. Curcumin-pretreated
cells were exposed to UVB (200J/m
2), and thereafter were
subjected to Annexin V-FITC binding assay, followed by
FACS analysis. As shown in Figure 1C, the percentage of
apoptosis increased in cells exposed to UVB (33.68±0.85%),
while apoptosis was signiﬁcantly reduced in the presence of
curcumin (14.59±0.70). These data suggest that curcumin
has the ability to attenuate UVB-induced cellular insults.
To examine if curcumin would protect cells directly exposed
to the most prevalent ROS, H2O2 and chemical paraquat, a
producer of ROS, hLECs were treated with curcumin (5mM).
After 12h, cells were subjected to H2O2 (200mM) or paraquat
(1mM) for variable time intervals as shown in Figures 1D–I.
Cell viability experiments showed that addition of curcumin in
culture protected the cells against H2O2- and paraquat-
induced death. Quantitation by staining with H2-DCF-DA
dye
6 established a lower prevalence of ROS in curcumin-
treated cells exposed to either of the stressors (Figure 1E,
dark gray bars versus black bars; Figure 1H, dark gray bars
versusblackbars).However,DCFﬂuorescenceisnotspeciﬁc
for H2O2, and other oxidants such as O2
_ and NO may also
oxidizeH2DCFinDCF.Thus,measuredﬂuorescencereﬂects
overall oxidative stress in cells.
23
Next, we examined and determined the type of cell death,
performing Annexin V-FITC binding assay, followed by FACS
analysis. Figures 1Fa and b and Figures 1Ia and b are re-
presentatives of the experiments showing photomicrographs
taken after 48h of exposure to stressors. Moreover, Annexin
V-FITC and propidium iodide (PI) staining demonstrated that
curcumin signiﬁcantly inhibited apoptotic cell death induced
by H2O2 or paraquat (Figures 1Fc versus d; Figures 1Ic versus
d). In contrast, untreated cells were susceptible to identical
oxidative stressors. As shown in Figures 1F and I, the
percentage of apoptosis increased in cells exposed to H2O2,
while the presence of curcumin signiﬁcantly inhibited apop-
tosis (*Po0.001).
Curcumin inhibited UVB-, H2O2- or paraquat-induced
lipid peroxidation and rescued hLECs. To test anti-lipid
peroxidation (LPO) activity of curcumin in hLECs, cells
untreated or pretreated with curcumin (5mM) were exposed
to UVB (100 or 200J/m
2) (Figure 1J), H2O2 (100 or 200mM)
(Figure 1K) or paraquat (1 or 2mM) (Figure 1L). The cells
were processed for LPO assay, which monitors levels of
malondialdehyde (MDA) and 4-hydroxyalkenals in unstable
lipid peroxide decomposition. As shown in earlier studies,
24
LPO level was signiﬁcantly retarded in treated cells com-
pared to untreated controls (Figures 1J–L, gray bars versus
black bars). Taken together, the data disclosed that curcumin
has the potential to protect against LPO-induced cell injuries.
Prdx6-knockdown cells revealed that curcumin’s
protective efﬁcacy was associated with Prdx6 expression.
To assess if curcumin exerts its protective action, at least in
part, by regulating Prdx6 expression, hLECs were trans-
fected with Prdx6 antisense (Prdx6-As) or empty vector
(Figure 2a).
3,25 After 48h, cells were exposed to UVB or
H2O2 or paraquat, and cell viability was determined
by 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2
to 4-sulfophenyl)-2H-tetrazolium salt (MTS) assay. Following
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Cell Death and Diseasenormalization of transfection efﬁciency, data showed that the
viability of even curcumin-treated cells with Prdx6-As was
signiﬁcantly decreased compared to that of cells transfected
with vector (Figure 2, black bars versus gray bars).
hLECs treated with curcumin displayed enhanced
expression of Prdx6 mRNA and protein. To test whether
curcumin induces the expression of Prdx6 in hLECs, we
investigated the effect of curcumin on the levels of Prdx6
mRNA and protein in hLECs. We treated hLECs with
curcumin (2.5 or 5mM) or vehicle containing Dulbecco’s
modiﬁed Eagle’s medium (DMEM) medium. Real-time PCR
analysis revealed the signiﬁcant increase of Prdx6 mRNA in
curcumin-treated cells (Figure 4b), and the maximum
expression level could be detected at 5mM curcumin con-
centration. Next, to determine whether Prdx6 protein was
inﬂuenced by curcumin treatment, western analysis revealed
increased expression of Prdx6 protein (Figure 4c, upper
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Figure 1 (A) Curcumin protected hLECs against UVB exposure, optimized ROS expression and reduced apoptotic cell death. Increase in survival of curcumin-treated
hLECs exposed to UVB. Cells were treated with 5mM of curcumin or dimethyl sulfoxide (DMSO) (a control vehicle). After 12h, cells were submitted to UVB (200J/m
2), and
effectson cellgrowth andviabilityweredeterminedafter24,48 and 72h by MTSassay.(B)Effect of curcuminon loweringROSexpression.Cells weretreatedwith DMSOor
5mMofcurcuminandafter12hwereexposedtoUVB(200J/m
2).ROSexpressionwasmeasuredat24,48 and72hbyreplacingthemediumwithHank’smediumcontaining
10mM H2-DCF-DA at Ex485/Em530nm. (C, left panel) hLECs 7 10
5 were cultured and pretreated with DMSO (a) or curcumin (Cur; b) and then exposed to UVB
(200J/m
2). After 48h, cells were photomicrographed. Arrows indicate dead cells. (Right panel) Cells were trypsinized and the percentage of apoptotic cells was monitored
by Annexin V-FITC staining, followed by ﬂuorescence-activated cell sorter (FACS) analysis. A representative photomicrograph (left panel) and FACS analysis of Annexin
V-FITC and PI staining were provided. Results are expressed as mean±S.D. for three replicate determinations for each treatment group, and were signiﬁcant (Po0.001)
compared with solvent (DMSO) control indicated by an asterisk (*). (D) Curcumin enhanced cell viability and blunted ROS expression and apoptotic cell death. hLECs
2 10
4 were cultured in 48-well plate and treated with curcumin (5mM) or DMSO (control vehicle). Cells were subjected to H2O2 (200mM). Cell viability was tested with
MTS assay at 24, 48 and 72h. (E) Curcumin attenuation of ROS induction by H2O2.h L E C s1 10
4 were cultured in 96-well plate, treated with curcumin (5mM) and
e x p o s e dt oH 2O2 (200mM).
7 ROS expression was quantiﬁed with H2-DCF-DA ﬂuorescence dye at Ex485/Em530nm with plate reader; results are presented as
a histogram. (F) Curcumin negatively regulated the vulnerability of hLECs to H2O2-evoked apoptotic cell death. DMSO- or curcumin-treated hLECs were cultured and
exposed to H2O2 (200mM). After 48h, cells were trypsinized and the percentage of apoptotic cells was monitored by Annexin V binding assay, followed by FACS
analysis.(Leftpanel)RepresentativephotomicrographofH2O2-inducedapoptosisinuntreated(a)andcurcumin-treated(b)cells.Arrowdenotesdeadcell.(Rightpanel)
RepresentativeFACSanalysisofAnnexinV-FITCandPIstainingwithcontrolvehicleDMSO(c)andcurcumin(d).Experimentswereperformedintriplicateandrepeated
atleastthreetimes,andtheresults areexpressedas means±S.D.(*Po0.001).(G)CurcuminpotentiatedhLECsviabilitybyblockingROSgenerationandprogression
of apoptosis against paraquat-induced insults. Curcumin- or DMSO-treated hLECs cultured in 48-well plates containing medium were subjected to paraquat (1mM), an
oxidative stressor. Cell viability assay (MTS assay) was performed at 24, 48 and 72h. The histogram is representative of three experiments. (H) Curcumin limited
paraquat-induced ROS expression in LECs. hLECs cultured in 96-well plate were treated with DMSO (vehicle) or curcumin (5mM), and submitted to H2-DCF-DA dye,
ROS expression assay (24, 48 and 72h) following paraquat addition as described earlier. The histogram is representative of ﬂuorescence, which is directly proportional
to intracellular ROS levels. (I) Curcumin protected hLECs from apoptotic cell death caused by paraquat-induced oxidative damage. Photomicrograph represents hLECs
treatedwithDMSO(a)andcurcumin(b)followingparaquataddition.Arrowindicateswhiteroundeddeadcell(leftpanel).(Rightpanel) RepresentativeFACSanalysisof
Annexin V-FITC and PI staining. hLECs were cultured and pretreated with curcumin (Cur) for 12h and then exposed to paraquat (1mM). After 48h, cells were
trypsinized and thepercentageofapoptotic cells was monitored by Annexin Vbindingassay, followed byFACS analysis. Datawere derivedfrom threeexperiments and
expressedas means±S.D.*Po0.001.(J)or(K)or(L)Curcumindelivery toculturedhLECsattenuatedUVB-,H2O2- orparaquat-inducedLPOprocessinhLECs.Cells
were either treated with DMSO (a control vehicle) or curcumin (5mM), or then exposed to stressors, UVB (J)o rH 2O2 (K) or paraquat (L) to generate oxidative stress.
After 48h, cells were assessed for levels of LPO using LPO assay as ascribed in commercial kit. Histogram values are mean±S.D. of three independent experiments.
Asterisks indicate statistically signiﬁcant difference (Po0.001 versus control). The results were derived from three experiments
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Cell Death and Diseasepanel) after treatment, consistent with an increase of Prdx6
mRNA expression (Figure 4b).
Prdx6 promoter contains three functional Sp1 sites and
all sites contributes differentially in Prdx6 transcription,
and responsive to curcumin treatment. Because of our
ﬁnding that curcumin induced the expression of Prdx6
mRNA, we analyzed putative transcription factor binding
sites in Prdx6 promoter. In silico analysis of 50-ﬂanking region
ranging from  839 to þ109 disclosed that Prdx6 promoters
contained three putative Sp1-response elements (GC-boxes)
located at –19/27 (nGCCCGCCCGn), –61/69 (nCCCGCCC-
CGn) and –82/89 (nCCCCGCCCn) (Figures 3 and 4a).
Based on the analysis of Sp1 sites, we sequentially engineered
the mutant constructs mutated at each individual site, at two
sites or at all three sites of wild-type chloramphenicol acetyl-
transferase (CAT) construct. Designated as Mut-1, Sp1-1;
Mut-2, Sp1-2; Mut-3, Sp1-3 and Mut-1þ2þ3, these
constructs were utilized for transactivation experiments in
hLECs or Drosophila cell lines (SL2) (Figure 3).
To examine whether curcumin-mediated increased expres-
sion of Prdx6 transcription is Sp1-dependent, hLECs trans-
fected with wild-type CAT or its various Sp1 site-speciﬁc
mutant constructs linked to CAT or empty CAT vector
(Figure 4a) were treated with curcumin at levels of 2.5 or
5mM, and processed for CAT assay. Transfection with con-
structs with mutation at either site of Sp1-response elements
showed inhibition of CAT activity, and that activity was
Sp1-response element-dependent (Figure 4a). Importantly, the
CAT activity of Prdx6 promoter with all disrupted Sp1 binding
elements was signiﬁcantly reduced and that was indistin-
guishablefromCAT-vectorvalues(Figure4a).Furthermore,a
decline in promoter activity due to disruption of one or more
Sp1 sites (Mut-1, Mut-2, Mut-3 or Mut-1þ2þ3) suggested
that all Sp1 siteswere functional and contributed to controlling
Prdx6 promoter activity. In parallel experiment, we examine
whether curcumin alters the transcriptional activity of Prdx6
promoter. Results showed that treatment of curcumin pro-
moted the transcriptional activity of wild-type Prdx6 promoter
in LECs, but failed to promote transactivation of mutant Prdx6
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Figure 2 Reduced expression of Prdx6 affected the protective potential of curcumin against stressors. hLECs were transfected with Prdx6-As or empty vector.
3,25 After
48h, cells of each group were pooled and harvested in 48-well plate, and subjected to stressors, followed by survival assay. A fraction of cells from each pool were used to
assess the expression levels of Prdx6. (a) Western analysis of vector- (lane 1) and Prdx6-As- (lane 2) transfected cells. (b) Histogram showing the values of MTS assay of
vector and Prdx6-As-transfected cells following curcumin treatment. Results are mean±S.D. of three experiments
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Figure3 Aconstructlinkingthe50-proximalregulatorregionofthePrdx6promotertoCATreportergene.Thesequencerangingfromnucleotides 839to þ109contains
three putative Sp1 binding sites as predicted by MatInspector (Genomatix), a Web-based computer analysis program. The consensus sequences for the predicted Sp1 sites
(G/C-boxes) are shown in bold. Asterisks denote sites of Sp1, and the sites were mutated to examine the binding afﬁnity of each site to Sp1 and their contribution in promoter
activity.Underliningisusedtoshowtheoligonucleotidesemployedingel-shiftandgel-shiftdeletionassays.NucleotidesinitalicsreﬂectprimerpairusedforChIPexperiments.
The transcription start site is indicated by þ1, and SacI and XhoI restriction sites used for marking Prdx6-CAT-constructs are shown in bold
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Cell Death and Diseasepromoter disrupted at Sp1 site(s) (Figure 4a, gray and black
bars), suggesting that curcumin induced Prdx6 transcription
via activation of Sp1.
Curcumin-mediated increased coexpression of Prdx6
and Sp1 mRNA and protein. To determine whether hLECs
treated with curcumin displayed increased expression of
endogenous Prdx6 mRNA and protein, hLECs were treated
with curcumin at dose levels of 2.5 and 5mM for 48h. As
expected, the expression of Sp1 (Figure 4b, black bar) and
Prdx6 (Figure 4b, gray bar) was signiﬁcantly increased in
cells treated with curcumin. Next, we measured Sp1 and
Prdx6 protein levels in curcumin-treated cells. The expres-
sion of Sp1 as well as Prdx6 was increased, and the increased
expression was clearly curcumin concentration-dependent
(Figure 4c, Sp1, middle panel; Prdx6, upper panel).
Upregulation of Prdx6 expression is Sp1 expression-
dependent, and Sp1 is a regulator of Prdx6 transcription. To
examine whether cells overexpressed with Sp1 displayed
higher expression of endogenous Prdx6, and increasing
amounts of pCMV-Sp1 co-transfection increased Prdx6 pro-
moter activity, hLECs were overexpressed with increasing
concentrations of pCMV-Sp1 (0, 2, 4 and 8mg) or empty
pCMV vector. Real-time PCR analysis showed a higher level
of Prdx6 mRNA in Sp1-overexpressing cells, which was
increased with increasing abundance of Sp1 (Figure 5a, gray
bar and black bar; 0 versus 2 versus 4 versus 8mg). Next, we
performed western analysis using Prdx6, Sp1 and b-actin
antibodies as described in ‘Materials and Methods’. Results
showed Sp1-mediated upregulation of Prdx6 gene, in a
dose-dependent manner. Next, we also tested the effect
of Sp1 overexpression on Prdx6 promoter activity. hLECs
were co-transfected with wild-type Prdx6 promoter (Figures 3
and 4a) linked to CAT or promoter constructs mutated at all
Sp1 sites (Mut-1þ2þ3) along with pCMV-Sp1 expression con-
struct (4mg). Figure 5c shows that Sp1 overexpression (4mg)
signiﬁcantly enhanced transcription of Prdx6 promoter (wild-type,
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Control
2.5M Curcumin
5M Curcumin
CAT Activity (O.D at 405 nm)
Sp1
Site2
Sp1
Site1
Sp1
Site3
CAT
+109 -839
-19/27 -61/69 -82/89 WT
Sp1
Site2
Sp1
Site1
Sp1
Site3
CAT
+109 -839
Mut-1
CAT Vector
Sp1
Site2
Sp1
Site1
Sp1
Site3
CAT
+109 -839
Mut-1+2+3
Sp1
Site2
Sp1
Site1
Sp1
Site3
CAT
+109 -839
Mut-2
Sp1
Site2
Sp1
Site1
Sp1
Site3
CAT
+109
-839
Mut-3
Sp1
(~90kDa)
Prdx6
(~24kDa)
-actin
(~42kDa)
0
0.0
0.5
1.0
1.5
2.0
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
P
r
d
x
6
a
n
d
 
S
p
1
 
/
β
-
a
c
t
i
n
 
m
R
N
A
Cur (M)
Cur (M)
*
Prdx6
Sp1
5.0 2.5 0
5.0 2.5
Figure 4 (a) Induction of Sp1-mediated transcriptional activation on the Prdx6 gene promoter by curcumin in hLECs. (Left half) Schematic representation of Sp1-site-
directed mutants of Prdx6 promoter linked to CAT. (Right half) CAT activity of the mutant constructs (Mut 1 to Mut 1þ2þ3) and empty CAT vector in hLECs untreated
(open bars) and curcumin-treated (2.5mM, gray bars; 5mM, black bars). Values of empty CAT vector were insigniﬁcant. All data are presented as the mean±S.D. derived
fromthreeindependentexperiments.Curcumin-mediatedincreasedexpressionofPrdx6mRNAandproteinwasSp1expression-dependent.hLECsweretreatedwith2.5and
5mM of curcumin or dimethyl sulfoxide (DMSO) (control vehicle). After 48h, RNA and protein were isolated and real-time polymerase chain reaction (PCR) (b) and western
analysis (c) were performed. (a) Histogram represents the data mean±S.D. obtained from three independent experiments. (c) Expression levels of Prdx6 (upper panel) and
Sp1 (middle panel) following the treatment with curcumin. Lower panel shows the protein bands of b-actin. *Po0.001
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Cell Death and Diseaseblack bar). This activation effect of Sp1 was ablated for
mutant promoter (Figure 5c), demonstrating that the Sp1-
responsive element in Prdx6 promoter was responsible for
Sp1 activity.
Sp1-deﬁcient cells, SL2 and artemisinin and mithra-
mycin A, inhibitors of Sp1, conﬁrmed that Sp1 is a
transactivator of Prdx6 promoter. To examine and verify
transcriptional activation of the Prdx6 promoter by Sp1, we
performed transient co-transfection experiments in Sp1-
deﬁcient Drosophila Schneider (SL2) cells with the expres-
sion vector pPac-Sp1, encoding Sp1
26 (purchased from
Addgene, Cambridge, MA, USA) and WT-Prdx6-CAT or
Mut-1 or Mut-2 or Mut-3 (Figures 3 and 4a) reporter
construct. Figure 6a shows the Sp1-dependent
transcriptional activity of Prdx6 promoter in SL2 cells.
Coexpression of Sp1 resulted in a B10-fold increase in
CAT activity of WT promoter. In contrast, CAT activity of
mutant promoter was reduced signiﬁcantly, and each mutant
promoter (disrupted Sp1 sites) displayed its contribution in
transactivation of Prdx6 promoter (Figure 6a, gray bars).
To further determine whether Sp1 activates Prdx6 tran-
scription through its responsive elements (GC-boxes), we
applied the Sp1 inhibitors artemisinin (ART) and mithramycin
A (Mithra-A)
27,28 and tested the effect of these agents on the
CAT activity controlled by Prdx6 promoter (Figures 6b and c).
hLECsweretransientlytransfectedwithWT-Prdx6-CATpromoter
or empty CAT vector, and treated with increasing concentra-
tions of ART and Mithra-A (Figures 6b and c). As shown in
Figures 6b and c, ART and Mithra-A at dose levels of 200mM
and 50nM, respectively, both showed a strong concentration-
dependent inhibition of Prdx6 promoter transcription (black
bars).
In vivo and in vitro DNA–protein binding assays dis-
closed that Sp1 directly and speciﬁcally bound to its
response elements in the Prdx6 promoter. To study
further whether Sp1 directly binds to putative Sp1-responsive
site(s) (GC-box) present within speciﬁc regions of endogenous
Prdx6 promoter, chromatin immunoprecipitation (ChIP) assay
was performed with crosslinked nucleoproteins isolated from
hLECs and antibody speciﬁc to Sp1. Transcription factor(s)
contained in chromatin could be immunoprecipitated by Sp1
antibody, but not precipitated with nonspeciﬁc IgG used as
control. Next, DNA isolated from immunoprecipitates was
analyzed by speciﬁc primers. Figure 7a shows that, in
comparison to control IgG, the Prdx6 promoter sequence
was enriched and detected in the Sp1-Ab precipitates. In
contrast, the Prdx6 promoter was not detected in precipitates
with control IgG.
Sequence analyses as well as the above data demon-
strated that Prdx6 promoter spanning from  208 to þ27 is
rich in GC and contains three GC-boxes, Sp1 binding sites.
We designated these Sp1-1 (Site 1), Sp1-2 (Site 2) and Sp1-3
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Figure 5 LECs overexpressing Sp1 displayed elevated expression of Prdx6 mRNA and protein. hLECs were transfected either with pCMV-vector (4mg) or pCMV-Sp1
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Cell Death and Disease(Site 3) (Figure 3). Chemically synthesized oligos containing
each putative GC-box element as well as their corresponding
mutants (Figure 7b) were radiolabeled (
32p) and were used to
ascertain if Sp1 in nuclear extract directly and speciﬁcally
bound to each site present in Prdx6 promoter. Gel-shift assay
revealed that nuclear extracts from hLECs interacted with
each probe containing Sp1 site(s) derived from Prdx6 pro-
moter and formed shifted bands Cm with wild-type probe(s)
(Figure 7b, lanes 1, 3, 5 and 7). Binding was totally eliminated
when Sp1-depleted nuclear extract (preabsorbed with antibody
speciﬁctoSp1)wasaddedtothereactionmixture(lanes6and8).
Furthermore, we also performed gel-shift mobility assay
using SL2 cells following pPac-Sp1 or pPac-0 (empty vector).
Gel-shift experiments with protein extract isolated from Sp1-
deﬁcient SL2 cells following transfection with pPac-Sp1 or
vector, pPac-0, showed that Sp1-transfected extract bound to
probederivedfrom Prdx6promoter-containingSp1 site.A Cm
complex occurred between WT probe and nuclear extract
from Sp1 transfectants (Figure 7c, lane 1). The data revealed
that Sp1 in nuclear extract directly and speciﬁcally bound to
each of three sites.
Curcumin induced enhanced binding activity of Sp1 to
Prdx6 promoter. To determine whether curcumin-mediated
protective activity in hLECs involves an increase of DNA-
binding activity of Sp1, nuclear extracts from untreated and
curcumin-treated cells were examined in gel-shift mobility
assay. We randomly selected an oligomer probe containing
Sp1 sites (Site 2) derived from Prdx6 promoter (Figures 7b
and d) and utilized it to examine DNA-binding afﬁnity of
Sp1 in nuclear extract isolated from curcumin-treated cells.
Nuclear extract from curcumin-treated cells formed a stronger
shifted complex designated as Cm (Figure 7d, lane 4).
Titration of nuclear extracts from both treated and untreated
cells and their binding to Sp1 probe further indicated that
nuclear extracts from curcumin-treated cells had greater
binding activity (Figure 7b, lanes 1–3 versus 4–6). A band
(NS) appeared in all lanes and is nonspeciﬁc and demonstrated
that not all nuclear proteins in curcumin-treated cells were
altered.
Oxidative stressors did not alter curcumin’s ability to
upregulate Sp1-dependent Prdx6 protein and mRNA. To
investigate whether redox environment alters curcumin-
induced Sp1 regulation of Prdx6 expression, we submitted
untreated and curcumin-treated cells to oxidative stresses
resulting from H2O2 (200mM), paraquat (1mM) or UVB
(200J/m
2) exposure for variable time periods (24, 48 and
72h). Western analysis of protein extracted from cells re-
vealed that Prdx6 protein was upregulated, and the upregulation
was Sp1 expression-dependent (Figures 8Aa and b, black
bar). Next, we tested Prdx6 mRNA level using real-time PCR.
As expected, cells treated with curcumin showed increased
Prdx6 as well as Sp1 mRNA expression (Figures 8Ba and b,
black bars) in a time-dependent manner. However, signi-
ﬁcantly increased Prdx6 and Sp1 mRNA were noticeable in
cells co-treated with curcumin and H2O2 (48h, black bars).
We think that higher expression of Prdx6 or Sp1 may be
associated with a coordinated effect of oxidative stress and
curcumin, as oxidative stress may stimulate similar survival
pathway(s) by cells, conferring resistance against stressors
during an acute phase of stress. Similar results were
obtained when cells were exposed to UVB or paraquat
(data not shown).
Curcumin failed to exert its protective effect against
stressors in cells lacking Prdx6. To test if induction of
naturally occurring Prdx6 by curcumin is responsible for
curcumin-mediated protection of LECs, cells deﬁcient in
Prdx6 should be less able to resist oxidative stresses, we
conducted survival assay in LECs derived from Prdx6
knockout mice (Prdx6
 / ) and wild-type (Prdx6
þ/þ) cells
subjected to oxidative stressors, UVB, or H2O2 or paraquat
for 48h. As reported earlier,
2,3,6 MTS assay revealed that
Prdx6
 /  cells were more susceptible to all of the stressors,
and curcumin treatment did not produce protection against
the oxidative stress (Figures 9a–c, gray bars). In contrast,
signiﬁcant curcumin-mediated cellular protection was observed
in Prdx6
þ/þ cells (Figure 9, black bars), suggesting that
Prdx6 is an essential molecule for curcumin-mediated
cellular protection during stress, at least for LECs.
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Cell Death and DiseaseDiscussion
The abnormal processes induced by ROS-driven oxidative
stress may be a major mechanism underlying abnormal
physiological changes in cells that have reduced levels of
cytoprotective proteins, such as Prdx6.
2,3,6,7,9 Considering
the well-established cytoprotective potential of Prdx6,
3,4,6,7,9,29
we studied the underlying mechanism of Prdx6 regulation
and ways in which Prdx6 might be used for therapeutic
intervention. Abundant evidence now exists showing that
consumption of some natural compounds, including curcu-
min, reduces the risk of ROS-mediated disorders.
14,15,30,31
We found that a low concentration (5mM) of curcumin is able
to mount protection of LECs against a variety of oxidative
stressors (UVB or H2O2 or paraquat), and acts by optimizing
ROS levels and thereby inhibiting apoptosis (Figure 1). Our
recent studies have shown that Prdx6 deﬁciency is a cause of
initiation of ER stress, and deﬁcient cells undergo sponta-
neous apoptosis. However, attenuation of apoptotic signaling
in these cells as well as delaying cataractogenesis in animal
model system by delivery of Prdx6
2,3,6,7,9,32 clearly demonstrates
the biological importance of Prdx6. Curcumin exercises its
protective function by inducing the expression of antioxidant
enzymes in various cell types.
14,15,33 We found that curcumin
activates Prdx6 expression in hLECs (Figures 4b and c).
The antioxidant mechanism of curcumin has been the
subject of debate for more than a decade. In our investigation,
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Figure 7 (a) ChIP analysis revealed that Sp1 bound to Prdx6 promoter in vivo. ChIP assay was carried out by using ChIP-IT Express (Active Motif, Carlsbad, CA, USA).
(Upperhalf) Schematic illustration of proximalpromoter regionof Prdx6-containing Sp1 bindingsites. Chromatin samplespreparedfrom LECs subjected to ChIPassaywith a
ChIP grade antibody against Sp1 or control IgG. The DNA fragments were used as templates and ampliﬁed by using primers designed to amplify  208 to þ27 region of the
Prdx6 promoter bearing Sp1 sites (**) and contiguoussequence ( 2229 to  2356) to whichSp1 does not bind (*). Polymerasechain reaction (PCR) products were resolved
intoagarosegelandvisualizedwithethidiumbromidestaining.(Lowerpanel)PhotographoftheampliﬁedDNAbandvisualizedwithethidiumbromidestaining.MW,molecular
weightmarker.(Lowerhalf)PrimersusedforampliﬁcationofspeciﬁcregioncontainingSp1sites(**) andnotrelatedtoSp1bindingSp1sites(*).(b)Sp1inthenuclearextract
of hLECs bound directly to its responsive elements in the Prdx6 promoter. (Left panel) Gel-shift assay was conducted with the nuclear extracts isolated from hLECs and
radiolabeled probes derived from Prdx6 promoter containing Sp1 sites. A Cm (Sp1/DNA) complex occurred (lanes 1, 3, 5 and 6) with wild-type (WT) probes; in contrast, no
complex formation could be detected with mutant probe (lanes 2 and 4). (Right panel) Antibody depletion assay showing ablation of DNA and Sp1 complex (Cm). Nuclear
extracts isolated from cells were incubated with antibody speciﬁc to Sp1 at 41C. Following centrifugation, extracts were processed for gel-shift assay. No band was detected
when Sp1-speciﬁc antibody was added to deplete Sp1 in nuclear extract with either of the probes with Sp1 sites (lanes 6 and 8). Bold bases denote mutated base(s). (c)
ProteinextractedfromSL2cellsexpressedwithSp1boundtoSp1-responsiveelementsinPrdx6promoter.Sp1-deﬁcientSL2cellsweretransfectedwithpPac-Sp1orpPac-0
plasmids. Protein was extracted and processed with radiolabeled probes containing Sp1 sites. Reaction mix was subjected to gel-shift assay. A Cm complex was formedwith
extract from pPac-Sp1-transfected cells (lane 1); in contrast, no complex was evident with extracts from pPac-0-transfected cells or mutant probes (lanes 2–4). (d) Curcumin
ameliorated the interaction of Sp1 with its responsive elements in the Prdx6 promoter. hLECs were cultured in the presence of dimethyl sulfoxide (DMSO) (control vehicle) or
curcumin and nuclear extracts were isolated as described, and were processed for gel-shift assay using radiolabeled probes with Sp1 sites. A strong Cm (Sp1/DNA) complex
occurred in cells treated with curcumin (lanes 4–6), in comparison to untreated cells (lanes 1–3). (e) Histogram represents densitometry analysis of DNA–protein complex
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Cell Death and Diseasecurcumin-treated cells showed signiﬁcant increase in Prdx6
mRNA, which was dose-dependent (Figures 4b and c).
Analysis of Prdx6 gene promoter revealed the presence of
three functional Sp1 sites (Figures 3 and 4a). However, Sp1-
Site 1 has greater activation potential than Sites 2 and 3
(Figure 4a). This different activation potential may be
explained by diversity in Sp1 core consensus elements that
affects the binding afﬁnity of Sp1 protein to each site, or,
probably, recruitment of other cofactors to the sites that
may cooperatively and coordinately participate in controlling
Prdx6 transcription, depending on cellular requirements.
34,35
Furthermore, in vivo DNA and protein binding experiments
(ChIP assay) with antibody speciﬁc to Sp1 revealed that Sp1,
indeed, binds speciﬁcally to GC-rich fragments spanning
from  208 to þ27nts containing GC-boxes. A gel-shift assay
further showed that Sp1 binds directly to all three Sp1
response elements (Site 1:
19nGCCCGCCCGn
27; Site 2:
61nCCCGCCCCGn
69; and Site 3:
82nCCCCGCCCn
89) pre-
sent in Prdx6 promoter (Figures 3, 7b and c). However, these
sequences are different from each other, and divergent from
Sp1 core consensus element (nGGGGCGGGn). Curcumin
has been shown to inﬂuence the activity or expression of
various transcription factors such as NF-kB, Ap1, Sp1 and so
forth, and thereby to modulate antioxidants expression.
14,36
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Figure 8 Curcumin promoted Sp1-dependent increased expression of Prdx6 protein and mRNA in hLECs facing oxidative stress. (A) Cells were exposed to 5mM
curcuminorcontrolvehicle(dimethylsulfoxide(DMSO))andsubmittedtoH2O2-(200mM)inducedoxidativestress.Cellextractswereisolatedfor24,48and72h,andresolved
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by western analysis with Prdx6 (a), Sp1 (b) or b-actin (c) antibody. The histogram
displays relative-protein band density. (B) Real-time polymerase chain reaction (PCR) showing expression levels of Prdx6 and Sp1 mRNA. RNA was isolated from untreated
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internal control. Values are represented as a histogram, obtained from three independent experiments. Asterisk denotes statistically signiﬁcant difference (Po0.001). Similar
results were obtained from the experiments with UVB and paraquat (data not shown)
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Cell Death and DiseaseOur current study clearly shows that curcumin induces the
coexpression of Sp1 and Prdx6, and delivers its Prdx6
overexpression activity by enhancing Sp1 expression and
thereby increasing DNA-binding and promoter activities
(Figures 6 and 7d). In addition, we carried out DNA-Sp1
binding and transactivation experiments in Sp1-deﬁcient
Drosophila cells (SL2). These experiments further conﬁrm
that Sp1 functionally binds and activates transcriptional
activity of Prdx6 promoter (Figures 6a and 7c). This was
further supported by experiments Mithra-A and ART, known
Sp1 inhibitors (Figures 6b and c). As Mithra-A directly binds to
GC-rich DNA sequence, it is used to explore the sequence
speciﬁcity of DNA-binding factors including Sp1.
29 ART, a
naturally occurring component of Artemisia annua, is able to
downregulate transcription factor Sp1.
27 Taken together, the
data indicate that curcumin’s novel mode of protective action
arises from transcriptional activation of Prdx6 expression,
which is in turn dependent on Sp1 expression, which is
invoked by curcumin itself. Initially, Sp1 was considered a
constitutive activator of housekeeping genes, but it is now
known that growth factor signals inﬂuenced by curcumin or
other factors may change the transcriptional activity of Sp1,
37
and that several Sp1 target genes are related to cell survival
and cell growth.
38,39 Curcumin has been shown to exert its
biologicaleffects throughseveral important molecular targets,
including transcription factors NF-kB, Ap1 and Sp1.
15,17,18
Our data, however, show that Sp1 directly and speciﬁcally
interacts with its site(s) (GC-boxes) in Prdx6 promoter
(Figures 6 and 7a).
Curcumin has been shown to have signiﬁcant antioxidant
activitybothinvivoandinvitro.
33Oxidativestresssigniﬁcantly
decreasescelldensity inhLECs,
7UVB directlydamagesDNA
and the process is linked to increasing ROS level.
7 Among
a great variety of ROS, H2O2 plays a pivotal role, because
it is generated from nearly all sources of oxidative stress.
Even endogenous H2O2 can enter the cells and induce
cytotoxicity due to its high membrane permeability.
40
Importantly, eye lenses from Prdx6-deﬁcient mice are highly
vulnerable to oxidative stress and develop cataract.
6 Our
current research showed that stimulation of naturally occur-
ring Prdx6 in LECs by delivery of curcumin enhanced LECs’
survival against stressors (Figures 1, 2, 8 and 9). These
results highlighted the potential use of curcumin to postpone
or delay the onset of cataractogenesis.
In summary, this study shows, for the ﬁrst time, the novel
mechanism of curcumin-mediated protection of hLECs,
involving Sp1-induced upregulation of Prdx6. We found that
curcumin stimulates Prdx6 gene transcription via Sp1 regula-
tion, and that adding curcumin stimulates the Prdx6 protein
andmRNA,therebyprovidingcytoprotectionagainstoxidative
stressors. In addition, our data reveal the presence of three
functional Sp1 sites in Prdx6 promoter, each with different
activation potential. These sites, we surmise, are responsible
for controlling and ﬁne tuning of Prdx6 expression in
accordance with cellular requirement(s) to maintain cellular
homeostasis. The results of this research should allow
us to design new therapies or combinations of therapies –
‘transcription-based inductive therapies’ – to attenuate dele-
terious signaling in situations involving physiological and
environmental stress, and to take steps to prevent/delay the
initiation and progression of cataractogenesis, including
diseases associated with aging in general.
Materials and Methods
Cell culture. Human lens epithelial cells (hLECs) (a kind gift of Dr. Venkat N
Reddy, Eye Research Institute, Oakland University, Rochester, MI, USA) were
maintained in DMEM with 15% fetal bovine serum, 100mg/ml streptomycin and
100mg/ml penicillin in 5% CO2 environment at 371C as described previously. Cells
were harvested and cultured in 96-, 24-, 48- or 6-well plates and 100mm Petri
dishes according to the requirement of the experiment. To examine the effect of
curcumin, cells were treated with different concentrations (2.5, 5 or 10mMi n
complete medium) of curcumin for variable time intervals. A stock solution of
curcumin (10mM) was prepared in DMSO and diluted in culture medium keeping
the ﬁnal DMSO concentration at o0.05% and same concentration of DMSO was
usedasvehicle.Curcumin(catalogno.C7727)anditsinhibitors,ARTandMithra-A,
were purchased from Sigma Aldrich (St. Louis, MO, USA).
Generationand validationof LECs isolated fromlenses of Prdx6
 / 
and Prdx6
þ/þ mice. All animal experiments followed the recommendations
set forth in the Statement for the Use of Animals in Ophthalmic Research by the
Association for Research in Vision and Ophthalmology. Animal studies were
approved by the University of Nebraska Medical Center (Omaha, NE, USA). LECs
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Figure 9 Prdx6-deﬁcient cells provided evidence that curcumin exerted its cytoprotective action via upregulation of Prdx6 expression in hLECs facing oxidative stresses.
Wild-type (Prdx6
þ/þ) and knockout (Prdx6
 / ) LECs were cultured in 48-well plate containing DMEM medium with or without curcumin (5mM). Cells were submitted to
oxidative stressors UVB (200J/m
2)( a), or H2O2 (200mM) (b) or paraquat (1mM) (c). Following incubation for 48h, viability of cells was assessed using MTS assay.
2
Representative histograms displaying relative viability of untreated or curcumin-treated Prdx6
 /  (gray bars) and Prdx6
þ/þ (black bars) LECs following oxidative stress.
Asterisk denotes statistically signiﬁcant difference (Po0.001)
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 / ) and wild-type (Prdx6
þ/þ) mice
were generated and maintained in DMEM with 10% fetal bovine serum, as
described earlier.
6 Prdx6
 /  129/Sv mice were generated at Harvard Medical
School under the supervision of Dr. David R Beier. For the this study, we used
Prdx6
 /  mutant mice of pure 129 background, and, as controls, wild-type 129/Sv
inbred mice of the same sex and age (Prdx6
þ/þ). All animals were maintained
under speciﬁc pathogen-free conditions in an animal facility. LECs were isolated
from mice of identical age, and western analysis was carried out to conﬁrm the
presence of aA-crystalline, a speciﬁc marker of LECs. Cells from 3 to 5 passages
were used for the experiments.
Construction of Prdx6-As. hLECs cDNA library was used to isolate Prdx6
cDNA having a full-length open reading frame. A full-length Prdx6-As construct was
madebysubcloningPrdx6cDNAintoapcDNA3.1/NT-GFP-TOPOvectorinreverse
orientation. Plasmid was ampliﬁed following TOP 10 bacterial cells transformation
as described earlier.
Cell survival assay (MTS assay). A colorimetric MTS assay (Promega,
Madison, MI, USA) was performed as described earlier.
2,6 Brieﬂy, 2 10
4 cells
were cultured in 48-well plate and pretreated with curcumin (5mM), and after 12h,
cellswereexposedtoUVB(200J/m
2),H2O2(200mM)orparaqaut(1mM)for24,48
or 72h. This assay of cellular proliferation uses MTS (Promega). Upon being added
to medium containingviable cells, MTS is reduced to a water-soluble formazan salt.
The A490nm value was measured after 4h with an ELISA reader.
Assay for intracellular redox state. Intracellular redox state levels were
measured using the ﬂuorescent dye, H2-DCF-DA as described earlier.
2,6 Cells
(1 10
4) were cultured in 96-well plates and pretreated with curcumin, and after
12h,cellsweresubjectedtoUVB(200J/m
2),H2O2(200mM)orparaqaut(1mM)for
24, 48 and 72h. Cells were washed once with HBSS and incubated in the same
buffer containing10mM of H2-DCF-DA.It is a nonpolarcompoundthatis converted
intoapolarderivative(dichloroﬂuorescein)bycellularesterasefollowingincorporation
into cells. Following 30min of incubation at room temperature, intracellular
ﬂuorescence was detected with excitation at 485nm and emission at 530nm
(Ex485/Em530) using Spectra Max Gemini EM (Molecular Devices, Sunnyvale,
CA, USA).
Apoptosis assay. Apoptosis was measured using ﬂow cytometry to quantify
the levels of oxidative stress-induced apoptotic cells. The Annexin V assay was
performed using the FITC Annexin V Apoptosis Detection Kit I (BD Biosciences,
San Jose, CA, USA). Brieﬂy, hLECs (7 10
5) were seeded in 100mm plates and
treated with curcumin (5mM), and after 12h, cells were exposed to UVB or H2O2 or
paraquat for 48h. Cells were washed twice with ice-cold PBS (phosphate-buffered
saline solution) and re-suspended in 1 10
5/100ml of binding buffer and incubated
with 5ml of Annexin V-FITC and 5ml of PI for 15min at room temperature in the
dark. After 15min of incubation, 400ml of binding buffer was added to make 500ml
ﬁnal volumes and ﬂow cytometry was performed within 1h.
LPOassay. LPOassaywascarriedoutaccordingtothemanufacturer’sprotocol
(Lipid Peroxidation Microplate Assay Kit; Oxford Biomedical Research, Rochester
Hills, MI, USA). The assay is based on the reaction of a chromogenic reagent,
N-methyl-2-phenylindole (R1), with MDA and 4-hydroxyalkenals at 451C. One
molecule of either MDA or 4-hydroxyalkenal reacts with 2 molecules of reagent R1
to yield a stable chromophore with maximal absorbance at 586nm. Brieﬂy, hLECs
(7 10
5) cells were seeded in 100mm plates and treated with curcumin, and after
12h of treatment, cells were exposed with UVB or H2O2 or paraquat for 48h. Cells
washed twice with ice-cold PBS and total cell lysates were prepared as described.
6
Equal amounts of protein were used for the assay. OD was measured at 586nm.
Protein expression assay. Cell lysates were prepared in ice-cold
radioimmunoprecipitation assay (RIPA) lysis buffer as described previously.
2,6
Equal amounts of protein samples were loaded into a 10% SDS gel, blotted onto
polyvinylidene ﬂuoride membrane (Perkin-Elmer Life Sciences, Santa Clara, CA,
USA)andimmunostainedwithprimaryantibodiesattheappropriatedilutions:Prdx6
monoclonal antibody (Lab Frontier, Seoul, South Korea); Sp1 rabbit polyclonal
and b-actin rabbit polyclonal (Abcam, Cambridge, MA, USA). Membranes were
incubated with horseradish peroxidase-conjugated secondary antibodies (1:1500
dilutions). Speciﬁc protein bands were visualized by incubating the membrane with
luminol reagent (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and exposing to ﬁlm
(X-Omat; Eastman Kodak Co., Rochester, NY, USA) and recorded with a FUJIFILM-
LAS-4000 luminescent image analyzer (FUJIFILM Medical Systems Inc., Stamford, CT,
USA).Toascertaincomparativeexpressionandequalloadingoftheproteinsamples,the
membrane stained earlier was stripped and reprobed with b-actin antibody (Abcam).
Construction of Prdx6 promoter-CAT reporter vector. The 50-ﬂanking
region ( 839 to þ109bp) (construct B) was isolated from mouse genomic DNA and
sequenced. A construct of  839bp was prepared by ligating it to basic pCAT vector
(Promega) using the SacIa n dXhoI sites. The plasmid was ampliﬁed and used for the
CAT assay. Primers used were as follows: 50-CTTCCTCTGGAGCTCAGAATTTAC-30
and 50-CAGGAACTCGAGGAAGCGGAT-30.
Site-directed mutagenesis. PCR-based site-directed mutagenesis was carried
out using the QuikChange site-directedmutagenesis kit (Invitrogen, Carlsbad, CA, USA),
followingthecompany’sprotocol.Brieﬂy,amino-acidexchangesSp1site1mutant(CCto
GG), Sp1 site 2 mutant (C to G) and Sp1 site 3 mutant (C to G) were generated by point
mutations in the Prdx6-CAT constructs. The following complementary primers were
used (changed nucleotides are in boldface type and underlined):
Sp1-Mut-1for,5 0-GATCTAGGTCTCCGCAGGAGCTAGCCCGCTGCTCAC
TG-30; Sp1-Mut-1rev,5 0-CAGTGAGCAGCGGGCTAGCTCCGGCGGAGA
CCTAGATC-30; Sp1-Mut-2for,5 0-GCCCTGCCCTAGCCCTGCCCACTCG
GCCAGCACTGATC-30; Sp1-Mut-2rev,5 0-GATCAGTGCTGGCCGAGTGG
GCAGGGCTAGGGCAGGGC-30; andSp1-Mut-3for,5 0-GCCGCCAGACTC
GCGGTCGCCTCACCTCGCCCTAGC-30; Sp1-Mut-3rev,5 0-GCTAGGGCG
AGGTGAGGCGACCGCGAGTCTGGCGGC-30.
Epicurean Coli XL1-Blue super-competent cells (Invitrogen) were transformed
with resultant plasmid, and clones were grown on Luria–Bertani/Amp Petri dishes.
The plasmid was ampliﬁed, and the mutation was conﬁrmed by sequencing.
TransfectionandCATassay. TheCATassaywasperformedusingaCAT-
ELISA kit (Roche Applied Science, Indianapolis, IN, USA). hLECs transfected/co-
transfectedusingSuperfectamine with Prdx6-CATreporter constructs(4mg)with or
without pCMV-Sp1(4mg) (Addgene) and pEGFP (1mg) to SEAP vector (1mg) and
treated with different concentrations of curcumin or Sp1 inhibitors. After 72h of
incubation, cells were harvested, extracts were prepared and protein was
normalized. CAT-ELISA was performed to monitor CAT activity following the
manufacturer’s protocol. Absorbance was measured at 405nm using a microtiter plate
ELISA reader. Transactivation activities were adjusted for transfection efﬁciencies using
GFP/SEAP values.
6
mRNAexpressionassay(real-timePCR). TotalRNAwasisolatedusing
the single-step guanidine thiocyanate/phenol/chloroform extraction method (Trizol
reagent; Invitrogen) and converted to cDNA using Superscript II RNAase
H
 Reverse Transcriptase. Quantitative real-time PCR was performed with SYBR
Green Master Mix (Roche Diagnostic Corporation, Indianapolis, IN, USA) in a
Roche LC480 Sequence detector system (Roche Diagnostic Corporation,
Indianpolis, IN, USA). PCR conditions consisted of 10-min hot start at 951C,
followed by 45 cycles of 10s at 951C, 30s at 601C and 10s at 721C. The primer
sequences were as follows: Prdx6, 50-GCATCCGTTTCCACGACT-30 and 50-
TGCACACTGGGGTAAAGTCC-30;S p 1 ,5 0-CCTGGATGAGGCACTTCTGT-30 and
50-GCCTGGGCTTCAAGGATT-30; b-actin, 50-CCAACCGCGAGAAGATGA-30 and 50-
CCAGAGGCGTACAGGGATAG-30. Expression levels of target genes were
normalized to the levels of b-actin as an endogenous control in each group.
ChIP assay. ChIP was performed using the ChIP assay kit (Active Motif,
Carlsbad, CA, USA) following the manufacturer’s protocol. The following antibodies
were used: normal mouse IgG and anti-Sp1 (Millipore, Billerica, MA, USA). Real-time
PCR ampliﬁcation was carried out using 4ml of DNA sample with primers (Prdx6
promoter bearing Sp1 sites, forward primer: 50-CGCAATTCTCGGTCTTGCGCTTC-30
and reverse primer: 50-GTGGTGACGCTGAGAACAAGGA-30, positions  208/þ27;
and contiguous sequence to which Sp1 does not binds, forward primer: 50-
CCTGGTTCCTTACATATAAGGC-30 and reverse primer: 50-cctggtatagtatatgtccctg-30,
positions  2356/ 2229 relativetotheAin theATGtranslation initiationcodon) speciﬁc
to the Prdx6 promoter. The ampliﬁcation of soluble chromatin before
immunoprecipitation was used as an input control. The program for quantiﬁcation
ampliﬁcation was 3min at 941C, 20s at 951C, 30s at 591Ca n d3 0sa t7 21C for 36
cycles in 25ml reaction volume.
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Cell Death and DiseaseDNA–protein interaction assays. Gel-shift assay was carried out using
nuclear extracts
2,6,25 isolated from hLECs to determine DNA-binding activity of Sp1
to their respective elements present in the Prdx6 promoter. Oligos consisting of
putative Sp1-binding elements were commercially synthesized (Invitrogen),
annealed and end-labeled with [g-
32P]ATP using T4 polynucleotide kinase (New
EnglandBiolabs,Ipswich,MA,USA).Thebindingreactionwasperformedin20mlof
binding buffer (20mM Tris-HCl (pH 8.0), 75mM KCl, 5% (v/v) glycerol, 50mg/ml
bovine serum albumin, 0.025% (v/v) Nonidet P-40, 1mM EDTA, 5mM dithiothreitol
and 1mg of poly (dI/dC). A measure of 5fmol of the end-labeled probe was
incubated on ice for 30min with variable concentrations of nuclear extract. The
samples were then loaded on 5% polyacrylamide gel in 0.5 TBE buffer for 2h at
10V/cm. The gel was dried and autoradiographed.
Statistical method. For all quantitative data collected. Statistical analysis was
conducted by Student’s t-test and was presented as mean±S.D. of the indicated
number of experiments. A signiﬁcant difference between control and treatment group
was deﬁned as P-valueof o0.05 and0.001forthreeor moreindependent experiments.
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